Lung cancer detection via CT scan
This article was originally published in The Gray Sheet
Among 484 asymptomatic individuals at risk for lung cancer who were diagnosed by low-dose CT in a study conducted from 1993 through 2005, the 10-year lung-cancer-specific survival rate was 80%. The study, published Oct. 26 in The New England Journal of Medicine, showed improved survival rates at 10 years in patients with clinical stage I lung cancer (88%), particularly those who underwent surgical resection within one month after diagnosis (92%). Currently in the U.S., 173,000 people are diagnosed with lung cancer each year, and 164,000 (95%) die from the disease, the report observes. Rates of detection and cost-effectiveness are comparable to those associated with mammographic screening for breast cancer, according to the study...
You may also be interested in...
A study questioning the validity of expensive CT scans for patients at high risk for lung cancer contradicts previous research and dampens the momentum of policy aimed to encourage CT lung cancer screening
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.